The effect of quantification standards used in real-time CMV PCR assays on guidelines for initiation of therapy in allogeneic stem cell transplant patients

被引：9

作者：

Harrington, S. M. ^{[1
]}

Buller, R. S.

Storch, G. A.

Li, L.

Fischer, S. H.

Murray, P. R.

Gea-Banacloche, J. C.

机构：

[1] NCI, Dept Lab Med, Warren Grant Magnuson Clin Ctr, NIH, Bethesda, MD 20892 USA

[2] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA

[3] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA

来源：

BONE MARROW TRANSPLANTATION | 2007年 / 39卷 / 04期

关键词：

D O I：

10.1038/sj.bmt.1705558

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：237 / 238

页数：2

共 9 条

[1]

[Anonymous], 2000, MMWR Recomm Rep, V49, P1

[2] Plasma polymerase chain reaction for cytomegalovirus DNA after allogeneic marrow transplantation - Comparison with polymerase chain reaction using peripheral blood leukocytes, pp65 antigenemia, and viral culture [J].

Boeckh, M ;

GallezHawkins, GM ;

Myerson, D ;

Zaia, JA ;

Bowden, RA .

TRANSPLANTATION, 1997, 64 (01) :108-113

[3] Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients [J].

Cortez, KJ ;

Fischer, SH ;

Fahle, GA ;

Calhoun, LB ;

Childs, RW ;

Barrett, AJ ;

Bennett, JE .

JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (07) :967-972

[4] Evaluation of the COBAS Amplicor HCMV Monitor for early detection and monitoring of human cytomegalovirus infection after allogeneic stem cell transplantation [J].

Lengerke, C. ;

Ljubicic, T. ;

Meisner, C. ;

Loeffler, J. ;

Sinzger, C. ;

Einsele, H. ;

Hebart, H. .

BONE MARROW TRANSPLANTATION, 2006, 38 (01) :53-60

[5] Dose-adjusted preemptive therapy for cytomegalovirus disease based on real-time polymerase chain reaction after allogeneic hematopoietic stem cell transplantation [J].

Mori, T ;

Okamoto, S ;

Watanabe, R ;

Yajima, T ;

Iwao, Y ;

Yamazaki, R ;

Nakazato, T ;

Sato, N ;

Iguchi, T ;

Nagayama, H ;

Takayama, N ;

Hibi, T ;

Ikeda, Y .

BONE MARROW TRANSPLANTATION, 2002, 29 (09) :777-782

[6] Screening for cytomegalovirus (CMV) infection in allogeneic bone marrow transplantation using a quantitative whole blood polymerase chain reaction (PCR) method: analysis of potential risk factors for CMV infection [J].

Qamruddin, AO ;

Oppenheim, BA ;

Guiver, M ;

Mutton, KJ ;

Chopra, R .

BONE MARROW TRANSPLANTATION, 2001, 27 (03) :301-306

[7] Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA [J].

Sanchez, JL ;

Storch, GA .

JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (07) :2381-2386

[8] Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation [J].

Solano, C ;

Muñoz, I ;

Gutiérrez, A ;

Farga, A ;

Prósper, F ;

García-Conde, J ;

Navarro, D ;

Gimeno, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (11) :3938-3941

[9] Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load ≥10000 copies/ml:: a safe and effective strategy for allogeneic stem cell transplant patients [J].

Verkruyse, LA ;

Storch, GA ;

Devine, SM ;

DiPersio, JF ;

Vij, R .

BONE MARROW TRANSPLANTATION, 2006, 37 (01) :51-56

← 1 →